Mode
Text Size
Log in / Sign up
Phase 4 Completed N=65 Randomized Single-blind Treatment

Sufentanil Infusion vs Sufentanil Bolus

Anesthesia
Source: ClinicalTrials.gov NCT04226495 ↗
Enrolled (actual)
65
Serious AEs
3.1%
Results posted
Feb 2023
Primary outcomePrimary: Time to Extubation — 230.5; 242.4 Minutes
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

Randomized single blind controlled clinical trial to test the benefit of sufentanil infusion over bolus dosing to reduce time to extubation and reduced length of ICU stay.

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to Extubation
230.5; 242.4
SECONDARY
Plasma Concentration
2.8; 2.8

Eligibility Criteria

Inclusion Criteria

  • Scheduled non-emergency cardiac surgical patients including those with planned procedures of CABG, AVR, and combined CABG and AVR
  • 19 to 80 years old
  • Planned pre-operative anesthesia screening visit and/or preoperative surgical clinic visit.
  • Inpatient subject that is scheduled (greater than 24hrs in advance) for a non-emergency cardiac surgical case

Exclusion Criteria

  • Sufentanil allergy
  • EF less than or equal to 30%
  • Moderate or severe right ventricular dysfunction,
  • Moderate pulmonary dysfunction, to include patients with at home 02 and/or daily bronchodilator therapy.
  • End Stage Renal Disease on Dialysis
  • Chronic Kidney Disease with GFR <30
  • Sternotomy Re-do
  • Emergency surgery
  • Greater than 4 units of RBCs or FFP combined
  • Mechanical circulatory support post-operatively such as ECMO, IABP, Impella
  • Not eligible for rapid wean extubation protocol
  • Requires infusion of sedative medication required during ICU admission
  • Greater than or equal to 15 minute ICU hold within PACU
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04226495). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search